• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阴道原发性癌的治疗与预后考量

Therapeutic and prognostic considerations in primary carcinoma of the vagina.

作者信息

Leminen A, Forss M, Lehtovirta P

机构信息

Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Finland.

出版信息

Acta Obstet Gynecol Scand. 1995 May;74(5):379-83. doi: 10.3109/00016349509024433.

DOI:10.3109/00016349509024433
PMID:7778433
Abstract

We analyzed 46 patients with primary carcinoma of the vagina treated between 1969 and 1990. Median age of the patients was 67 years (range 33-89 years). Most (52%) of them were obese and 35% were nulliparous. Four (9%) had suffered from other gynecologic carcinoma and had been operated six to 23 years before the current carcinoma. Forty (87%) patients had squamous cell carcinoma. Stage 0 (carcinoma in situ) was found in three (7%) cases and stage I-IV in 21 (54%), 10 (22%), four (9%) and eight (17%) cases, respectively. Most (81%) of the patients were treated with radiotherapy (alone or in combination with other treatments): combination of brachytherapy and external radiotherapy were used in 45% of the cases. Surgery was used in all stage 0 cases and in 52% of stage I cases. Recurrence of the disease was found in 20 (43%) cases during the follow-up of 10 years. Most often (40%) site of the recurrence was the vagina. Both 5- and 10-year survival were 38%. Stage and extent of the tumor were independent prognostic factors in stepwise multivariate analysis.

摘要

我们分析了1969年至1990年间接受治疗的46例原发性阴道癌患者。患者的中位年龄为67岁(范围33 - 89岁)。其中大多数(52%)为肥胖患者,35%未生育。4例(9%)曾患其他妇科癌症,在当前癌症发生前6至23年接受过手术。40例(87%)患者为鳞状细胞癌。0期(原位癌)3例(7%),Ⅰ - Ⅳ期分别为21例(54%)、10例(22%)、4例(9%)和8例(17%)。大多数(81%)患者接受了放射治疗(单独或与其他治疗联合):45%的病例采用了近距离放疗和外照射放疗联合。所有0期病例及52%的Ⅰ期病例采用了手术治疗。在10年的随访期间,20例(43%)患者出现疾病复发。最常见的复发部位(40%)是阴道。5年和10年生存率均为38%。在逐步多因素分析中,肿瘤的分期和范围是独立的预后因素。

相似文献

1
Therapeutic and prognostic considerations in primary carcinoma of the vagina.阴道原发性癌的治疗与预后考量
Acta Obstet Gynecol Scand. 1995 May;74(5):379-83. doi: 10.3109/00016349509024433.
2
Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors.阴道癌的根治性放疗:疗效及预后因素
Int J Radiat Oncol Biol Phys. 1996 Jul 15;35(5):891-905. doi: 10.1016/0360-3016(95)02394-1.
3
[Cancer of the vagina].[阴道癌]
Orv Hetil. 2011 Dec 4;152(49):1974-6. doi: 10.1556/OH.2011.29265.
4
Diagnostic, prognostic, and therapeutic considerations in invasive carcinoma of the vagina.阴道浸润癌的诊断、预后及治疗考量
Obstet Gynecol. 1972 Dec;40(6):843-50.
5
[Clinical analysis of 42 cases of primary malignant tumor in vagina].42例原发性阴道恶性肿瘤的临床分析
Zhonghua Fu Chan Ke Za Zhi. 2008 Dec;43(12):923-7.
6
Factors affecting long-term outcome of irradiation in carcinoma of the vagina.影响阴道癌放疗长期疗效的因素
Int J Radiat Oncol Biol Phys. 1999 Apr 1;44(1):37-45. doi: 10.1016/s0360-3016(98)00530-6.
7
Diagnosis of vaginal carcinoma from cytologic material.从细胞学材料诊断阴道癌。
Acta Cytol. 1974 Nov-Dec;18(6):494-503.
8
Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.上颌窦癌的治疗:1997年与1977年美国癌症联合委员会分期系统的比较
Cancer. 1999 Nov 1;86(9):1700-11.
9
Squamous cell carcinoma of the vagina.阴道鳞状细胞癌
Surg Clin North Am. 1978 Feb;58(1):25-38. doi: 10.1016/s0039-6109(16)41431-3.
10
The curative potential of radiation therapy in the treatment of primary vaginal carcinoma.放射治疗在原发性阴道癌治疗中的治愈潜力。
Am J Clin Oncol. 1996 Feb;19(1):39-44. doi: 10.1097/00000421-199602000-00009.

引用本文的文献

1
Radiotherapy for carcinoma of the vagina. Immunocytochemical and cytofluorometric analysis of prognostic factors.阴道癌的放射治疗。预后因素的免疫细胞化学和细胞荧光分析。
Strahlenther Onkol. 2013 May;189(5):394-400. doi: 10.1007/s00066-012-0291-0. Epub 2013 Apr 5.